side effects of a semaglutide Ozempic (semaglutide) is GLP-1 receptor agonist used for type 2 diabetes (and sometimes weight loss). Its range from common GI symptoms to rare but serious risks. ⸻ 🟡 Common Navigating Semaglutide Side Effects in

Since 1990, adult obesity has more than doubled, and adolescent obesity has quadrupled, underscoring a growing global health crisis

Eli Lilly's orforglipron an oral non-peptide small-molecule GLP-1 receptor agonist has reported positive Phase 3 results but is not FDA-approved as of April 2026

Some analyses show that, at current prices, GLP-1s may not be as cost effective as certain surgical alternatives

Those instructions come directly from the FDA prescribing information and exist because absorption depends on that quiet window

Semaglutide treats liver disease in two thirds of patients Date: May 4, 2025 Source: King's College London Summary: A groundbreaking international trial has found that semaglutide, a drug best known for treating diabetes and obesity, can also reverse a dangerous liver disease called MASH in nearly two-thirds of patients